Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flupirtine for painful HIV-associated sensory neuropathy in patients on opioids
ACTRN12608000315314Phase 2Completed
- Sponsor
- CNSBio
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of flupirtine in Sensory neuropathy (SN), sponsored by CNSBio. Primary endpoints: Efficacy of flupirtine for pain due to HIV-sensory neuropathy and Safety of flupirtine for pain due to HIV-sensory neuropathy. Started Sep 2007; status: completed.
02
Drugs
flupirtine
03
Conditions
Sensory neuropathy (SN)
Beyond the preview
Go deeper on ACTRN12608000315314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000315314.